Since CML is a marker of oxidative stress that contributes to the initiation and progression of liver injury [54] and ALT is a liver biomarker [55], we had expected a positive relationship between CML and ALT. The gene discussed is GPT; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.